PTGDR2 and cancer: Currently, GPR44 has drawn increasing attention for the pathogenesis of cancer-related inflammation, inflammation-induced cancer, diabetes, inflammatory bowel disease, chronic kidney diseases, osteoarthritis, central nervous system diseases, and alopecia [8].